A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Crohn's Disease
Related studies linked through entity extraction aliases.
Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative Colitis
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)
- Status
- COMPLETED
- Phase
- PHASE3
Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo), Following 3 Doses of Active Drug (CDP870).
- Status
- COMPLETED
- Phase
- PHASE3
Citrulline: A Plasmatic Marker to Assess and Monitor Small Bowel Crohn's Disease Patients
- Status
- COMPLETED
- Phase
- N/A
Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
COMMIT (Combination Of Maintenance Methotrexate-Infliximab Trial)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE2
Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents With Inflammatory Bowel Disease
- Status
- COMPLETED
- Phase
- NA
VSL#3 Versus Placebo in Maintenance of Remission in Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE4
Imuran Dosing in Crohn's Disease Study
- Status
- TERMINATED
- Phase
- PHASE2
Trial of Growth Hormone Therapy in Pediatric Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
An Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Nine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Imuran (Azathioprine) Dose-Ranging Study in Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE3
STA-5326 in Crohn's Disease Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE3
An Efficacy and Safety Study of Omega-3 Free Fatty Acids (Epanova™) for the Maintenance of Symptomatic Remission in Subjects With Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE3